CD Biosynsis pioneers the application of CRISPRi (CRISPR Interference) for precise and tuneable transcriptional knockdown in Bacillus subtilis. Unlike permanent gene knockout, CRISPRi utilizes catalytically dead Cas9 (dCas9) guided by a single guide RNA (sgRNA) to physically block the transcription of target genes, offering a powerful tool for gene function studies and metabolic flux optimization. This service is essential for researchers needing graded, reversible control over gene expression without making irreversible genomic modifications. Our optimized system ensures high repression efficiency, minimal off-target effects, and straightforward induction control, providing a superior solution for dynamically probing gene essentiality and engineering complex metabolic pathways.
Ready to gain dynamic control over gene expression in your B. subtilis system? The CRISPRi system is the ideal solution for fine-tuning metabolic bottlenecks and conducting sophisticated functional genomics screens. Contact the expert team at CD Biosynsis today for a detailed consultation on your specific gene repression needs. We offer comprehensive support, from customized sgRNA design to final strain validation, ensuring your project achieves its precise control objectives.
Get a Customized Project QuoteCRISPRi provides a significant advantage over traditional gene silencing methods by offering a highly specific, sequence-driven approach to gene knockdown. The system consists of the deactivated Cas9 (dCas9) fused to a repressor or simply acting as a physical roadblock, and an sgRNA that targets the dCas9 complex to the promoter or coding region of the target gene. This transcriptional interference allows for a fine-graded modulation of gene expression, crucial for studying dose-dependent gene effects or balancing the flux through complex metabolic network nodes.
Mechanism
dCas9 retains its DNA-binding capability but lacks nuclease activity, ensuring gene function is regulated through physical interference, not genome cleavage.
Repression Strength
By optimizing the position of sgRNA binding (e.g., near the transcriptional start site), we can achieve knockdown efficiency up to 99%.
Design Algorithms
Utilization of proprietary algorithms to design high-specificity sgRNAs, validated to avoid unintended repression of homologous genes.
Multiplexing
Design and delivery of multiple sgRNAs to simultaneously repress several target genes for complex metabolic fine-tuning.
Induction Strategy
dCas9 expression is often placed under an inducible promoter (e.g., xylose-inducible) allowing for temporal control over gene repression.
Reversibility
By removing the inducer, gene expression can be restored, which is essential for studying transient biological processes.
Metabolic Flux Optimization
Precisely titrate the expression of genes involved in competing metabolic branches or substrate consumption to maximize target compound yield.
Essential Gene Studies
Investigate the function of genes that are lethal when completely knocked out by applying partial, graded transcriptional knockdown.
Screening and Library Generation
Generate libraries of strains with varying degrees of repression for high-throughput screening of gene function and pathway sensitivity.
Graded Control
Ability to achieve a range of gene repression levels, unlike the all-or-nothing effect of gene knockout.
No Genome Cleavage
Safety benefit: The use of dCas9 avoids off-target DNA damage and maintains genomic integrity.
Rapid Implementation
Faster strain construction as only the sgRNA needs to be redesigned to target a new gene.
Multiplex Repression
Simultaneous and independent repression of multiple genes using co-expressed sgRNAs.
Our systematic procedure guarantees reliable integration and tuneable function of the CRISPRi system.
CRISPRi Strategy & sgRNA Design
dCas9 and sgRNA Vector Construction
Stable Strain Integration
Functional Validation (QC)
Strategy: Determine single or multiplex repression targets and the required repression level.
Design: Select high-efficacy sgRNA sequences to maximize transcriptional interference at the promoter or coding region.
Construction: Build the dCas9 expression vector (often chromosomally integrated for stability) and the sgRNA expression cassette.
Assembly: Ensure all components (inducible dCas9, sgRNA) are correctly assembled for co-expression.
Transformation: Introduce the engineered cassettes into B. subtilis competent cells.
Selection: Isolate colonies with confirmed stable integration of the complete CRISPRi system.
Still have questions about tuneable gene control?
Contact UsHow is CRISPRi different from traditional gene knockout?
CRISPRi (Interference) causes reversible transcriptional knockdown (inhibition of mRNA production) using dCas9, whereas gene knockout causes a permanent, irreversible deletion of the gene from the genome.
Can CRISPRi repress multiple genes simultaneously?
Yes. The system is highly adaptable for multiplexing, allowing the expression of multiple sgRNAs from a single cassette to repress several target genes at once, critical for complex metabolic pathway analysis.
What kind of control over repression strength is achievable?
Repression strength can be controlled in two ways: 1) by choosing the optimal sgRNA target site, and 2) by varying the concentration of the chemical inducer (e.g., IPTG or xylose) that controls dCas9 expression.
How do you confirm the repression efficiency?
We use Quantitative PCR (qPCR) to accurately measure the reduction in the mRNA level of the target gene upon induction, providing a precise, quantitative validation of the knockdown efficiency.
Is the CRISPRi system integrated into the chromosome?
For the highest stability and long-term research use, we recommend and primarily offer chromosomal integration of the dCas9 expression cassette. The sgRNA cassette may also be integrated or maintained on a stable plasmid, depending on project needs.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.